| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614617 Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 03/25/1997 | US5614505 Method of treating cancer with homo-oligonuleotides of 5-FU 5'-monophosphate |
| 03/25/1997 | US5614402 5' nucleases derived from thermostable DNA polymerase |
| 03/25/1997 | US5614390 Species-specific detection of Mycobacterium kansasii |
| 03/25/1997 | US5614386 And labeling of dna fragments by difluro-bora-diaza-indacenes as fluorophores for genetic analysis |
| 03/25/1997 | US5614365 DNA polymerase having modified nucleotide binding site for DNA sequencing |
| 03/25/1997 | US5614362 Nucleic acid hybridization assay for hepatitis B virus DNA |
| 03/25/1997 | US5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | CA1339010C Oligonucleotide polymeric support system |
| 03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | WO1997010332A2 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 03/20/1997 | DE19534046A1 Radio-iodinating oligo-nucleotide, protein or peptide |
| 03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/19/1997 | EP0763601A2 Homogeneous hybridization assay with label specific receptors |
| 03/19/1997 | EP0763599A2 DNA encoding thermostable pyrophosphatase |
| 03/19/1997 | EP0763542A2 Long-chain prenyl diphosphate synthase |
| 03/19/1997 | EP0763205A1 Nucleic acid sequences controlling lung cell-specific gene expression |
| 03/19/1997 | EP0763133A1 Method for detecting a target nucleic acid |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763051A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 03/19/1997 | EP0763050A1 Branched oligonucleotides as pathogen-inhibitory agents |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763009A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 03/19/1997 | EP0754302A4 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 03/19/1997 | EP0751948A4 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 03/19/1997 | EP0745135A4 Method for exponential amplification of nucleic acid by a single unpaired primer |
| 03/19/1997 | EP0678096B1 Synthesis of dimmer blocks and their use in assembling oligonucleotides |
| 03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
| 03/18/1997 | US5612473 Methods, kits and solutions for preparing sample material for nucleic acid amplification |
| 03/18/1997 | US5612468 Genetic engineering |
| 03/18/1997 | US5612215 Stromelysin targeted ribozymes |
| 03/18/1997 | US5612209 Allergies |
| 03/18/1997 | US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 03/13/1997 | WO1997009451A1 Cloned dna polymerases from thermotoga and mutants thereof |
| 03/13/1997 | WO1997009340A1 Compositions and methods for the synthesis of organophosphorus derivatives |
| 03/13/1997 | WO1997009337A1 Metallocene-phosphoramidite conjugates, process for their preparation and their use |
| 03/13/1997 | CA2233460A1 Compositions and methods for the synthesis of organophosphorus derivatives |
| 03/12/1997 | EP0761815A2 Bacillus thuringiensis sporulation gene |
| 03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
| 03/12/1997 | EP0760867A1 Compositions and methods relating to dna mismatch repair genes |
| 03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 03/12/1997 | EP0760857A1 Receptor for oncostatin m |
| 03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
| 03/12/1997 | EP0760674A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
| 03/12/1997 | EP0760666A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0636137B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 03/12/1997 | EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling. |
| 03/12/1997 | CN1145098A Comparative gene transcript analysis |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/11/1997 | US5610291 Glass fiber membranes modified by treatment with SiCl4, AlCl3 or BCl3 and washing with NaOH to set as a DNA Adsorbant |
| 03/11/1997 | US5610290 DNA purification by solid phase extraction using glass fiber membrane previously treated with trifluoroacetic acid, and then with fluoride ion, hydroxide ion, or Bcl3 |
| 03/11/1997 | US5610289 Backbone modified oligonucleotide analogues |
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus |
| 03/11/1997 | US5610050 Methods of preventing viral replication |
| 03/11/1997 | US5610017 Method for conducting a polymerase chain reaction using an improved electrochemiluminescent label |
| 03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
| 03/11/1997 | US5609826 Methods and apparatus for the generation of chemical libraries |
| 03/11/1997 | CA1338981C Biologically active proteins and a method for their production |
| 03/06/1997 | WO1997008345A1 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
| 03/06/1997 | WO1997008340A1 Amplification and detection of mycobacterium avium complex species |
| 03/06/1997 | WO1997008190A2 Compounds |
| 03/06/1997 | WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2230753A1 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
| 03/05/1997 | EP0760008A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis |
| 03/05/1997 | EP0760005A1 DETECTION AND DIFFERENTIATION OF $i(MYCOBACTERIUM TUBERCULOSIS) COMPLEX BACTERIA BY DIRECT VARIANT REPEAT OLIGOTYPING |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759998A1 Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759993A1 DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR $g(a)-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759979A1 Antisense inhibition of hepatitis c virus |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759927A1 Pteridine nucleotide analogs as fluorescent dna probes |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0674647B1 Analytical technique for oligonucleotide analogs |